News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,896 Results
Type
Article (16059)
Company Profile (117)
Press Release (366714)
Multimedia
Podcasts (56)
Webinars (12)
Section
Business (114105)
Career Advice (833)
Deals (18961)
Drug Delivery (53)
Drug Development (31865)
Employer Resources (62)
FDA (9022)
Job Trends (7870)
News (176245)
Policy (13465)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
Academia (1380)
Accelerated approval (10)
Adcomms (2)
Allergies (75)
Alliances (35062)
ALS (44)
Alzheimer's disease (648)
Antibody-drug conjugate (ADC) (180)
Approvals (9200)
Artificial intelligence (447)
Autoimmune disease (62)
Automation (31)
Bankruptcy (154)
Best Places to Work (6643)
BIOSECURE Act (8)
Biosimilars (34)
Biotechnology (87)
Bladder cancer (62)
Brain cancer (29)
Breast cancer (263)
Cancer (2197)
Cardiovascular disease (149)
Career advice (709)
Career pathing (14)
CAR-T (200)
CDC (24)
Cell therapy (496)
Cervical cancer (21)
Clinical research (26332)
Collaboration (1236)
Compensation (230)
Complete response letters (12)
COVID-19 (1274)
CRISPR (85)
C-suite (489)
Cystic fibrosis (61)
Data (2679)
Decentralized trials (1)
Denatured (27)
Depression (46)
Diabetes (220)
Diagnostics (5172)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (165)
Drug pricing (48)
Drug shortages (6)
Duchenne muscular dystrophy (89)
Earnings (41254)
Editorial (18)
Employer branding (10)
Employer resources (55)
Events (54360)
Executive appointments (553)
FDA (10661)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (904)
Gene editing (173)
Generative AI (38)
Gene therapy (354)
GLP-1 (319)
Government (1530)
Grass and pollen (4)
Guidances (226)
Healthcare (10165)
HIV (23)
Huntington's disease (14)
IgA nephropathy (26)
Immunology and inflammation (73)
Immuno-oncology (19)
Indications (50)
Infectious disease (1421)
Inflammatory bowel disease (81)
Inflation Reduction Act (8)
Influenza (73)
Intellectual property (151)
Interviews (169)
IPO (8236)
IRA (15)
Job creations (1486)
Job search strategy (593)
JPM (23)
Kidney cancer (6)
Labor market (27)
Layoffs (144)
Leadership (12)
Legal (2994)
Liver cancer (43)
Longevity (6)
Lung cancer (245)
Lymphoma (172)
Machine learning (34)
Management (21)
Manufacturing (529)
MASH (37)
Medical device (11945)
Medtech (11995)
Mergers & acquisitions (11373)
Metabolic disorders (419)
Multiple sclerosis (64)
NASH (3)
Neurodegenerative disease (127)
Neuropsychiatric disorders (24)
Neuroscience (1123)
NextGen: Class of 2026 (3668)
Non-profit (1686)
Now hiring (15)
Obesity (156)
Opinion (124)
Ovarian cancer (92)
Pain (107)
Pancreatic cancer (101)
Parkinson's disease (119)
Partnered (20)
Patents (305)
Patient recruitment (249)
Peanut (33)
People (34032)
Pharmaceutical (18)
Pharmacy benefit managers (13)
Phase 1 (9632)
Phase 2 (11818)
Phase 3 (7744)
Pipeline (2587)
Policy (104)
Postmarket research (540)
Preclinical (4326)
Press Release (66)
Prostate cancer (96)
Psychedelics (7)
Radiopharmaceuticals (177)
Rare diseases (326)
Real estate (3423)
Recruiting (26)
Regulatory (10848)
Reports (21)
Research institute (1335)
Resumes & cover letters (124)
Rett syndrome (21)
RNA editing (9)
RSV (41)
Schizophrenia (38)
Series A (163)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (3)
Spinal muscular atrophy (62)
Sponsored (20)
Startups (2546)
State (2)
Stomach cancer (2)
Supply chain (49)
Tariffs (16)
The Weekly (28)
Vaccines (536)
Venture capital (45)
Weight loss (59)
Women's health (46)
Worklife (7)
Date
Today (3)
Last 7 days (276)
Last 30 days (1125)
Last 365 days (14962)
2026 (1414)
2025 (15327)
2024 (19034)
2023 (22376)
2022 (31168)
2021 (32880)
2020 (31037)
2019 (26430)
2018 (19931)
2017 (19188)
2016 (18064)
2015 (20883)
2014 (15406)
2013 (12959)
2012 (14046)
2011 (14336)
2010 (13050)
Location
Africa (378)
Alabama (69)
Alaska (6)
Arizona (179)
Arkansas (10)
Asia (25118)
Australia (4408)
California (5345)
Canada (1699)
China (550)
Colorado (285)
Connecticut (239)
Delaware (110)
Europe (51867)
Florida (914)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (480)
India (34)
Indiana (264)
Iowa (8)
Japan (272)
Kansas (101)
Kentucky (15)
Louisiana (19)
Maine (23)
Maryland (728)
Massachusetts (3594)
Michigan (278)
Minnesota (409)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (16)
Nevada (53)
New Hampshire (83)
New Jersey (1571)
New Mexico (18)
New York (1441)
North Carolina (776)
North Dakota (9)
Northern California (2264)
Ohio (171)
Oklahoma (16)
Oregon (24)
Pennsylvania (1017)
Puerto Rico (19)
Rhode Island (35)
South America (579)
South Carolina (60)
South Dakota (1)
Southern California (2288)
Tennessee (103)
Texas (880)
United States (19960)
Utah (213)
Vermont (1)
Virginia (91)
Washington D.C. (23)
Washington State (511)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
382,896 Results for "innerscope hearing technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
The deal will help bolster Eli Lilly’s growing hearing loss portfolio, which is anchored by the gene therapy AK-OTOF.
January 28, 2026
·
2 min read
·
Tristan Manalac
BioMidwest
InnerScope Hearing Technologies (OTC:INND) Launches its iHEAR Matrix OTC Hearing Aids in 4218 Walmart Stores
InnerScope Hearing Technologies Inc. announced it is launching the iHEAR Matrix Rechargeable OTC Hearing Aids with Walmart as part of Walmart’s OTC hearing aid display fixture located in 4,218 Walmart stores nationwide.
November 16, 2023
·
7 min read
Biotech Beach
InnerScope Hearing Technologies (OTC: INND) Launches Hearing
InnerScope Hearing Technologies Inc. announced the launch of its HearingAssist brand FDA-Registered Over-the-Counter Rechargeable Hearing Aids including its EZHear Neckband Amplifier and other assorted HearingAssist branded hearing and hearing related supplies on Walgreens.com.
April 5, 2023
·
8 min read
Press Releases
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
Patents strengthen Envoy Medical’s innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.
September 10, 2025
·
8 min read
Press Releases
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
Patents issued in the U.S., Australia, and Hong Kong advance Envoy Medical’s innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.
August 20, 2025
·
8 min read
Biotech Beach
InnerScope Hearing Technologies (OTC: INND) Subsidiary HearingAssist Celebrates World Hearing Day By Offering OTC Hearing Aids in 1500+ Walmart Vision Centers
InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Over-the-Counter Hearing Aid space announced together with its subsidiary, HearingAssist Inc.
March 2, 2023
·
8 min read
BioMidwest
InnerScope Hearing Technologies (OTC: INND) Retains SmallCapVoice.com to Amplify Investor Relations and Digital Marketing Initiatives
InnerScope Hearing Technologies Inc. announced has retained SmallCapVoice.com, a seasoned, yet dynamic firm with a focus on compliant investor relations, digital marketing, and community management services tailored for publicly traded companies.
September 7, 2023
·
7 min read
Biotech Bay
InnerScope Hearing Technologies Announces its Hearing Assist Brand of OTC Hearing Aids on RiteAid.com
InnerScope Hearing Technologies Inc. announced today that its subsidiary HearingAssist Americas’s #1 Affordable OTC Hearing Brand has launched a complete line of FDA-Registered Over-the-Counter (“OTC”) Rechargeable Hearing Aids (“HearingAssist OTC Hearing Aids”) and assorted hearing and hearing related supplies on RiteAid.com.
November 22, 2022
·
7 min read
Business
InnerScope Hearing Technologies (OTC: INND) Announces Profitable Year-End 2022 Financial Results
InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Over-the-Counter hearing aid space, announced its unaudited financial results for the full year ended December 31, 2022.
April 3, 2023
·
10 min read
Press Releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
·
3 min read
1 of 38,290
Next